Hassan M, Merza N, Nawras Y, et al. Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation. 2025;13(S3). doi:10.46570/utjms-2025-1397